Structure activity of C-terminal modified analogs of Ac-CCK-7.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  International journal of peptide & protein research

• Publication date

  2009-01-12

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/J.1399-3011.1992.TB01592.XPMID 1385345
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure activity studies of tryptophan30 modified analogs of Ac-CCK-7.

  2009cited by this paper
• Cholecystokinin (pancreozymin). Synthesis and properties of the N alpha-acetyl-derivative of cholecystokinin 27-33.

  2009cited by this paper
• Cholecystokinic activity of N alpha-hydroxysulfonyl-[Nle28,31]CCK26-33 analogues modified at the C-terminal residue.

  2009cited by this paper
• 2-Phenylethyl ester and 2-phenylethyl amide derivative analogues of the C-terminal hepta- and octapeptide of cholecystokinin.

  2009cited by this paper
• Down-regulation and recycling of high affinity cholecystokinin receptors on pancreatic acinar cells.

  1991cited by this paper
• Cholecystokinin and anxiety.

  1990cited by this paper
• Central and peripheral vagal transport of cholecystokinin binding sites occurs in afferent fibers.

  1990cited by this paper
• The asymmetric synthesis of .alpha.-amino acids. Electrophilic azidation of chiral imide enolates, a practical approach to the synthesis of (R)- and (S)-.alpha.-azido carboxylic acids

  1990cited by this paper
• Evidence that decreased feeding induced by systemic injection of cholecystokinin is mediated by CCK-A receptors.

  1989cited by this paper
• The role of CCK, caerulein, and CCK antagonists in nociception

  1989cited by this paper
• Structure-activity relationship studies on cholecystokinin: analogues with partial agonist activity.

  1988cited by this paper
• Pylorectomy reduces the satiety action of cholecystokinin.

  1988cited by this paper
• Proteins but not amino acids, carbohydrates, or fats stimulate cholecystokinin secretion in the rat.

  1986cited by this paper
• Two brain cholecystokinin receptors: implications for behavioral actions.

  1986cited by this paper
• Derivatives of CCK-(26-32) as cholecystokinin receptor antagonists in guinea pig pancreatic acini.

  1984cited by this paper
• Synthesis of potent heptapeptide analogues of cholecystokinin.

  1984cited by this paper
• Cholecystokinin receptors: biochemical demonstration and autoradiographical localization in rat brain and pancreas using [3H] cholecystokinin8 as radioligand

  1984cited by this paper
• An SN2 deprotection of synthetic peptides with a low concentration of hydrofluoric acid in dimethyl sulfide: evidence and application in peptide synthesis

  1983cited by this paper
• Cholecystokinin-27-32-amide. A member of a new class of cholecystokinin receptor antagonists.

  1983cited by this paper
• Protein structure by Fourier transform infrared spectroscopy: second derivative spectra.

  1983cited by this paper
• Interactions of COOH-terminal fragments of cholecystokinin with receptors on dispersed acini from guinea pig pancreas.

  1982cited by this paper
• Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat.

  1981cited by this paper
• C-terminal octapeptide of cholecystokinin decreases food intake in man.

  1981cited by this paper
• Interaction of cholecystokinin with specific membrane receptors on pancreatic acinar cells.

  1980cited by this paper
• Preparation and application of Procion Yellow starch for amylase assay.

  1980cited by this paper
• Enantiomer labelling, a method for the quantitative analysis of amino acids.

  1978cited by this paper
• Tert-butoxycarbonylaminoacyl-4-(oxymethyl)-phenylacetamidomethyl-resin, a more acid-resistant support for solid-phase peptide synthesis.

  1976cited by this paper
• Cholecystokinin elicits the complete behavioral sequence of satiety in rats.

  1975cited by this paper
• Inhibition of gastric emptying is a physiological action of cholecystokinin.

  1975cited by this paper
• Mode of action of cholecystokinin and related peptides on gallbladder muscle.

  1973cited by this paper
• Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides.

  1970cited by this paper

• Structure-Activity Relationships and Characterization of Highly Selective, Long-Acting, Peptide-Based Cholecystokinin 1 Receptor Agonists.

  2019cites this paper
• Structural studies on radiopharmaceutical DOTA-minigastrin analogue (CP04) complexes and their interaction with CCK2 receptor

  2018cites this paper
• Alkylation and Related Reactions III

  2014cites this paper
• 5 – Alkylation and Related Reactions IV

  2014cites this paper
• THEMED SECTION: MOLECULAR PHARMACOLOGY OF G PROTEIN-COUPLED RECEPTORS REVIEW Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor

  2010cites this paper
• CCK-A AGONISTS : ENDEAVOURS INVOLVING STRUCTURE-ACTIVITY RELATIONSHIP STUDIES

  2010cites this paper
• Structure activity studies of tryptophan30 modified analogs of Ac-CCK-7.

  2009cites this paper
• Electrophilic Amination of Carbanions, Enolates, and Their Surrogates

  2009cites this paper
• New routes to beta-cycloalkylalanine derivatives using serine-derived organozinc reagents.

  2005cites this paper
• The design and synthesis of novel beta-substituted amino acids, bicyclic dipeptide mimetics, and their incorporation into cholecystokinin/opioidchimeric peptides

  2004cites this paper
• CCK1R agonists: a promising target for the pharmacological treatment of obesity.

  2003cites this paper
• New paradigm for drug design: Design and synthesis of novel biologically active peptides that are agonists at opioid receptors and antagonists at cholecystokinin receptors

  2003cites this paper
• Biological Effects of Newly Synthesized Cholecystokinin Analogs

  2000cites this paper
• Identification and initial structure-activity relationships of a novel class of nonpeptide inhibitors of blood coagulation factor Xa.

  1998cites this paper
• Cholecystokinin analogs with suppressed central activities.

  1998cites this paper
• Activity on the Gastrointestinal Tract

  1997cites this paper
• Comparative Conformational Analysis of CCK‐B Agonist Boc‐Trp‐Phg‐Asp‐(1‐Nal)‐NH2 and CCK‐B Antagonist Boc‐Trp‐Phg‐Asp‐(1‐Nal)‐N(Me)2 Using 1H NMR Spectroscopy and Restrained Molecular Dynamics

  1996cites this paper
• Role of N- and C-terminal substituents on the CCK-B agonist-antagonist pharmacological profile of Boc-Trp-Phg-Asp-Nal-NH2 derivatives.

  1996cites this paper
• Novel CCK Analogs for Studying CCK‐B Receptor

  1994cites this paper
• Binding of Cholecystokinin‐8 (CCK‐8) Peptide Derivatives to CCKA and CCKB Receptors

  1994cites this paper
• Evidence for cholecystokinin receptor subtype in endocrine pancreas.

  1994cites this paper
• Concepts and progress in the development of peptide mimetics.

  1993cites this paper
• Analogs of CCK incorporating conformationally constrained replacements for Asp32.

  1992cites this paper
• Analogs of Ac-CCK-7 incorporating dipeptide mimics in place of Met28-Gly29.

  1992cites this paper